Single-blind clinical trial of psychotherapy for treatment of psychogenic movement disorders

Parkinsonism Relat Disord. 2006 Apr;12(3):177-80. doi: 10.1016/j.parkreldis.2005.10.006. Epub 2005 Dec 20.

Abstract

Background: PMD are disabling, but lack any generally accepted treatment strategies.

Design/methods: Ten patients with PMD received treatment with Psychodynamic Psychotherapy. Patients were assessed with psychiatric rating scales and the movement disorder was rated by a blinded rater with the Psychogenic Movement Disorder Rating Scale (PMDRS).

Results: Total mean PMDRS (p = 0.0195), total PMDRS function scores (p = 0.0142), Hamilton depression scores (p = 0.009), Beck anxiety scores (p = 0.002), and GAF (p = 0.0083) all improved with psychotherapeutic intervention.

Conclusions: Psychotherapy and appropriate use of adjunct psychiatric medication can be a successful intervention for PMD.

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Anti-Anxiety Agents / therapeutic use
  • Antidepressive Agents / therapeutic use
  • Anxiety / drug therapy
  • Depression / drug therapy
  • Female
  • Humans
  • Male
  • Movement Disorders / psychology*
  • Movement Disorders / therapy*
  • Psychophysiologic Disorders / diagnosis
  • Psychophysiologic Disorders / therapy*
  • Psychotherapy / methods*
  • Single-Blind Method
  • Treatment Outcome

Substances

  • Anti-Anxiety Agents
  • Antidepressive Agents